Background Infection with Human Immunodeficiency virus (HIV) is an important risk factor for
Tuberculosis (TB). Anti-Retroviral Therapy (ART) has improved the prognosis of HIV and …

Background In sub-Saharan Africa, the burden of human immunodeficiency virus (HIV)–
associated tuberculosis is high. We conducted a trial with a 2-by-2 factorial design to assess …

Non-tuberculous mycobacteria (NTM) are a large family of acid-fast bacteria, widespread in
the environment. In children, NTM cause lymphadenitis, skin and soft tissue infections, and …

Objective: Thirty-six months of isoniazid preventive therapy (36IPT) was superior to 6 months
of IPT (6IPT) in preventing tuberculosis (TB) among HIV-infected adults in Botswana. We …

Introduction: Tuberculosis (TB) is a chronic infectious disease that has represented a major
health problem over the centuries. The human immune deficiency virus (HIV)/AIDS has …

Background The implementation of collaborative TB-HIV services is challenging. We,
therefore, assessed TB treatment outcomes in relation to HIV infection and antiretroviral …

Tuberculosis (TB) remains an important public health concern, and a leading cause of
disease and death worldwide. Mozambique is one of the few high TB burden countries …

Background Whether the incidence of tuberculosis in HIV-positive people receiving long-
term antiretroviral therapy (ART) remains above background population rates is unclear. We …

Background. Despite the benefits of antiretroviral therapy (ART), tuberculosis (TB) is the
leading cause of mortality among human immunodeficiency virus (HIV)-infected persons in …

Abstract Approximately 1.1 million, or 13%, of all TB cases in 2013 were coinfected with HIV,
and in some African countries, such as Botswana and Swaziland, 60–80% of TB cases are …